EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy

Jinming Xu, Jiaju Xu, Chengfang Sun, Xuhong He, Yichang Shu, Qi Huangfu, Longxiyu Meng, Zhengxin Liang, Jingchao Wei, Ming Cai, Jiaming Wen, Bohan Wang

Acta Biomaterialia · 2025-05 · 197 · 460-475

DOI: 10.1016/j.actbio.2025.03.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025-05. Verfasst von Jinming Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Silicon Dioxide, Nanoparticles, CRISPR-Cas Systems. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Program of Zhejiang Province, National Natural Science Foundation of China, Zhejiang Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsSilicon DioxideNanoparticlesCRISPR-Cas SystemsGenetic TherapyGene Transfer TechniquesHumansAnimalsCell Line, TumorPorosityMiceMice, Nude

Stichwörter der Autor:innen

Bladder cancerCRISPR/dCas9-SAMGene therapyMesoporous silica nanoparticlesMultiplex gene activation

Substanzen

Silicon Dioxide

Autor:innen und Institutionen

  • Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.
  • Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: caiming2002@hotmail.com.
  • Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: wenjiaming@zju.edu.cn.
  • Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: wangbohan@zju.edu.cn.

Förderung

  • Science and Technology Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Zhejiang Province Natural Science Foundation
  • China Postdoctoral Science Foundation

Zitieren

APA

Xu, J., Xu, J., Sun, C., He, X., Shu, Y., Huangfu, Q., Meng, L., Liang, Z., Wei, J., Cai, M., Wen, J., & Wang, B. (2025). Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy. Acta Biomaterialia, 197, 460-475. https://doi.org/10.1016/j.actbio.2025.03.032

Vancouver

Xu J, Xu J, Sun C, He X, Shu Y, Huangfu Q, et al. Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy. Acta Biomaterialia. 2025;197:460-475. doi:10.1016/j.actbio.2025.03.032

BibTeX
@article{Xu2025,
  author = {Xu, Jinming and Xu, Jiaju and Sun, Chengfang and He, Xuhong and Shu, Yichang and Huangfu, Qi and Meng, Longxiyu and Liang, Zhengxin and Wei, Jingchao and Cai, Ming and Wen, Jiaming and Wang, Bohan},
  title = {Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy},
  journal = {Acta Biomaterialia},
  year = {2025},
  volume = {197},
  pages = {460--475},
  doi = {10.1016/j.actbio.2025.03.032}
}
Kostenlos starten →